Product Information
DUAL ACTION PAIN 250-125 MG is a generic product labeled by Cardinal Health, priced at $0.0899 per EA under NDC 70000062201. Its NADAC has been published 112 times since May 8, 2024.
Strength
250; 125 mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000062201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA216592On Market Since
7/15/2023
Pharmacological Classes
Price Statistics
The NADAC for DUAL ACTION PAIN 250-125 MG has been published 112 times since May 8, 2024, and over the history we have for it it has risen 44.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0899 per EA |
|---|---|
| All-time high | $0.1086 (Jul 16, 2025) |
| All-time low | $0.0610 (May 22, 2024) |
| 52-week high | $0.1086 |
| 52-week low | $0.0839 |
| Median price | $0.0894 |
| Average price | $0.0870 |
| Largest weekly change | +15.2% (Jul 17, 2024) |
| Weeks tracked | 112 |
| Tracking since | May 8, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DUAL ACTION PAIN 250-125 MG?
The current National Average Drug Acquisition Cost (NADAC) for DUAL ACTION PAIN 250-125 MG, manufactured by Cardinal Health, is $0.0899 per EA (NDC 70000062201), effective Jun 24, 2026.
How has the price of DUAL ACTION PAIN 250-125 MG changed over time?
Over the history we have for it, the NADAC for DUAL ACTION PAIN 250-125 MG has risen 44.2%. It has been tracked across 112 weekly CMS publications since May 8, 2024.
What are the highest and lowest recorded NADAC prices for DUAL ACTION PAIN 250-125 MG?
Since May 8, 2024, the NADAC for DUAL ACTION PAIN 250-125 MG has ranged from a low of $0.0610 (May 22, 2024) to a high of $0.1086 (Jul 16, 2025), with a median of $0.0894 per EA.
Are there cheaper alternatives to DUAL ACTION PAIN 250-125 MG?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET, is $0.0844 per EA — about 6% below DUAL ACTION PAIN 250-125 MG.
Who manufactures DUAL ACTION PAIN 250-125 MG?
DUAL ACTION PAIN 250-125 MG (NDC 70000062201) is labeled by Cardinal Health, and CMS classifies it as a generic product.
Related Drugs
Same classification